Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16321 entries
Sorted by: Best Match Show Resources per page
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

Build and Broaden 3.0 AND Program Evaluation

[No authors listed]
GSID: ykdNFSTKyH0J
JJP Kastelein, SI van Leuven, L Burgess… - … England Journal of …, 2007 - Mass Medical Soc

Background Torcetrapib, an inhibitor of cholesteryl ester transfer protein, may reduce atherosclerotic vascular disease by increasing levels of high-density lipoprotein (HDL) cholesterol. Methods A total of 850 patients with heterozygous familial hypercholesterolemia underwent B-mode ultrasonography at baseline and at...

Cite
Kastelein, J. J., van Leuven, S. I., Burgess, L., Evans, G. W., Kuivenhoven, J. A., Barter, P. J., ... & Bots, M. L. (2007). Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. New England Journal of Medicine, 356(16), 1620-1630.
Kastelein, John JP, et al. "Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia." New England Journal of Medicine 356.16 (2007): 1620-1630.
Copy Download .nbib Format: MLA
A role of RIP3-mediated macrophage necrosis in atherosclerosis development

Science interventions

Han F, Huang Z, Li H, Ren J.
GSID: oQ6pQyWi-DwJ
J Lin, H Li, M Yang, J Ren, Z Huang, F Han, J Huang… - Cell reports, 2013 - Elsevier

Necrotic death of macrophages has long been known to be present in atherosclerotic lesions but has not been studied. We examined the role of receptor interacting protein (RIP) …

Cite
Lin, J., Li, H., Yang, M., Ren, J., Huang, Z., Han, F., ... & Han, J. (2013). A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell reports, 3(1), 200-210.
Lin, Juan, et al. "A role of RIP3-mediated macrophage necrosis in atherosclerosis development." Cell reports 3.1 (2013): 200-210.
Copy Download .nbib Format: MLA
PHYSICAL ARTEFACTS AND SIMULATION FOR UNDERSTANDING ATHEROSCLEROSIS: STEM EDUCATION AND MATHEMATICS LEARNING IN A …

STEM Education

Amado N, Carreira S.
GSID: y0qz3HQsaVQJ
S Carreira, N Amado - … in Education …, 2022 - openjournals.library.sydney.edu.au

… Interest in STEM education has increased worldwide, along with the concern for … STEM education. Some researchers have drawn attention to the role of mathematics in STEM education…

Cite
Carreira, S., & Amado, N. (2022, November). PHYSICAL ARTEFACTS AND SIMULATION FOR UNDERSTANDING ATHEROSCLEROSIS: STEM EDUCATION AND MATHEMATICS LEARNING IN A VOCATIONAL SCHOOL. In 7th STEM in Education Conference 2022 Proceedings.
Carreira, Susana, and Nélia Amado. "PHYSICAL ARTEFACTS AND SIMULATION FOR UNDERSTANDING ATHEROSCLEROSIS: STEM EDUCATION AND MATHEMATICS LEARNING IN A VOCATIONAL SCHOOL." 7th STEM in Education Conference 2022 Proceedings. 2022.
Copy Download .nbib Format: MLA
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis

Science interventions

Karunakaran D.
GSID: R6yXJ2mBHlwJ
D Karunakaran, M Geoffrion, L Wei, W Gan… - Science …, 2016 - science.org

… can be targeted in experimental atherosclerosis for both therapeutic and diagnostic interventions. In humans with unstable carotid atherosclerosis, … AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to...

Cite
Karunakaran, D., Geoffrion, M., Wei, L., Gan, W., Richards, L., Shangari, P., ... & Rayner, K. J. (2016). Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Science advances, 2(7), e1600224.
Karunakaran, Denuja, et al. "Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis." Science advances 2.7 (2016): e1600224.
Copy Download .nbib Format: MLA
[Prevention of coronary atherosclerosis: (I) Basic pathologic and etiopathogenic concepts].

Archivos del Instituto de Cardiologia de Mexico

Cueto García L, Barrios del Valle R, del Carmen Pérez G, Alva M, García Barcena I.
PMID: 2960289
Arch Inst Cardiol Mex. 1987 Jul-Aug;57(4):331-6.

No abstract available.

Cite
Cueto García L, Barrios del Valle R, del Carmen Pérez G, et al. Prevención de la ateroesclerosis coronaria: (I). Conceptos patológicos y etiopatogénicos básicos. [Prevention of coronary atherosclerosis: (I) Basic pathologic and etiopathogenic concepts]. Arch Inst Cardiol Mex. 1987;57(4):331-6
Cueto García, L., Barrios del Valle, R., del Carmen Pérez, G., Alva, M., & García Barcena, I. (1987). Prevención de la ateroesclerosis coronaria: (I). Conceptos patológicos y etiopatogénicos básicos. [Prevention of coronary atherosclerosis: (I) Basic pathologic and etiopathogenic concepts]. Archivos del Instituto de Cardiologia de Mexico, 57(4), 331-6.
Cueto García, L, et al. "Prevención de la ateroesclerosis coronaria: (I). Conceptos patológicos y etiopatogénicos básicos." [Prevention of coronary atherosclerosis: (I) Basic pathologic and etiopathogenic concepts]. Archivos del Instituto de Cardiologia de Mexico vol. 57,4 (1987): 331-6.
Cueto García L, Barrios del Valle R, del Carmen Pérez G, Alva M, García Barcena I. Prevención de la ateroesclerosis coronaria: (I). Conceptos patológicos y etiopatogénicos básicos. [Prevention of coronary atherosclerosis: (I) Basic pathologic and etiopathogenic concepts]. Arch Inst Cardiol Mex. 1987 Jul-Aug;57(4):331-6. Spanish. PMID: 2960289.
Copy Download .nbib Format: NLM
Coronary heart disease in women: evaluation and management.

Clinical obstetrics and gynecology

Wray RB.
PMID: 3067936
Clin Obstet Gynecol. 1988 Dec;31(4):955-62. doi: 10.1097/00003081-198812000-00022.

Coronary heart disease should not be considered a male dominated disease. The incidence of clinical CHD lags by several years in women, but it remains a leading cause of death and disability in the adult female. Risk factors for...

Cite
Wray RB. Coronary heart disease in women: evaluation and management. Clin Obstet Gynecol. 1988;31(4):955-62doi: 10.1097/00003081-198812000-00022.
Wray, R. B. (1988). Coronary heart disease in women: evaluation and management. Clinical obstetrics and gynecology, 31(4), 955-62. https://doi.org/10.1097/00003081-198812000-00022
Wray, R B. "Coronary heart disease in women: evaluation and management." Clinical obstetrics and gynecology vol. 31,4 (1988): 955-62. doi: https://doi.org/10.1097/00003081-198812000-00022
Wray RB. Coronary heart disease in women: evaluation and management. Clin Obstet Gynecol. 1988 Dec;31(4):955-62. doi: 10.1097/00003081-198812000-00022. PMID: 3067936.
Copy Download .nbib Format: NLM
Study of the correlation between the Type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis.

The Tokai journal of experimental and clinical medicine

Tagawa R, Hosaka T.
PMID: 2087705
Tokai J Exp Clin Med. 1990 Mar;15(1):45-50.

To investigate the relationship between the coronary-prone behavior pattern (Type A behavior pattern) and coronary artery disease, 159 patients were evaluated by coronary angiography (CAG) and the coronary-prone behavior pattern score (CBP score) as well as other coronary risk...

Cite
Tagawa R, Hosaka T. Study of the correlation between the Type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis. Tokai J Exp Clin Med. 1990;15(1):45-50
Tagawa, R., & Hosaka, T. (1990). Study of the correlation between the Type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis. The Tokai journal of experimental and clinical medicine, 15(1), 45-50.
Tagawa, R, and Hosaka, T. "Study of the correlation between the Type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis." The Tokai journal of experimental and clinical medicine vol. 15,1 (1990): 45-50.
Tagawa R, Hosaka T. Study of the correlation between the Type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis. Tokai J Exp Clin Med. 1990 Mar;15(1):45-50. PMID: 2087705.
Copy Download .nbib Format: NLM
[Morphology and histogenesis of atherosclerosis of the coronary vessels].

Bullettino delle scienze mediche

Mancini AM.
PMID: 5606043
Bull Sci Med (Bologna). 1967 Oct-Dec;139(4):450-1.

No abstract available.

Cite
Mancini AM. Morphologia ed istogenesi dell'aterosclerosi nel distretto coronarico. [Morphology and histogenesis of atherosclerosis of the coronary vessels]. Bull Sci Med (Bologna). 1967;139(4):450-1
Mancini, A. M. (1967). Morphologia ed istogenesi dell'aterosclerosi nel distretto coronarico. [Morphology and histogenesis of atherosclerosis of the coronary vessels]. Bullettino delle scienze mediche, 139(4), 450-1.
Mancini, A M. "Morphologia ed istogenesi dell'aterosclerosi nel distretto coronarico." [Morphology and histogenesis of atherosclerosis of the coronary vessels]. Bullettino delle scienze mediche vol. 139,4 (1967): 450-1.
Mancini AM. Morphologia ed istogenesi dell'aterosclerosi nel distretto coronarico. [Morphology and histogenesis of atherosclerosis of the coronary vessels]. Bull Sci Med (Bologna). 1967 Oct-Dec;139(4):450-1. Italian. PMID: 5606043.
Copy Download .nbib Format: NLM
Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India.

Frontiers in neurology

Khurana D, Mathur D, Prabhakar S, Thakur K, Anand A.
PMID: 23565106
Front Neurol. 2013 Apr 02;4:27. doi: 10.3389/fneur.2013.00027. eCollection 2013.

We aimed to identify the role of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein (MCP-1) as a serum biomarker of symptomatic carotid atherosclerotic plaque in North Indian population. Individuals with symptomatic carotid atherosclerotic plaque have high risk...

Cite
Khurana D, Mathur D, Prabhakar S, et al. Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India. Front Neurol. 2013;4:27doi: 10.3389/fneur.2013.00027.
Khurana, D., Mathur, D., Prabhakar, S., Thakur, K., & Anand, A. (2013). Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India. Frontiers in neurology, 427. https://doi.org/10.3389/fneur.2013.00027
Khurana, Dheeraj, et al. "Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India." Frontiers in neurology vol. 4 (2013): 27. doi: https://doi.org/10.3389/fneur.2013.00027
Khurana D, Mathur D, Prabhakar S, Thakur K, Anand A. Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India. Front Neurol. 2013 Apr 02;4:27. doi: 10.3389/fneur.2013.00027. eCollection 2013. PMID: 23565106; PMCID: PMC3613844.
Copy Download .nbib Format: NLM
Atherosclerosis: from biology to pharmacological treatment.

Journal of geriatric cardiology : JGC

Riccioni G, Sblendorio V.
PMID: 23097661
J Geriatr Cardiol. 2012 Sep;9(3):305-17. doi: 10.3724/SP.J.1263.2012.02132.

A recent explosion in the amount of cardiovascular risk has swept across the globe. Primary prevention is the preferred method to lower cardiovascular risk. Lowering the prevalence of obesity is the most urgent matter, and is pleiotropic since it...

Cite
Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol. 2012;9(3):305-17doi: 10.3724/SP.J.1263.2012.02132.
Riccioni, G., & Sblendorio, V. (2012). Atherosclerosis: from biology to pharmacological treatment. Journal of geriatric cardiology : JGC, 9(3), 305-17. https://doi.org/10.3724/SP.J.1263.2012.02132
Riccioni, Graziano, and Sblendorio, Valeriana. "Atherosclerosis: from biology to pharmacological treatment." Journal of geriatric cardiology : JGC vol. 9,3 (2012): 305-17. doi: https://doi.org/10.3724/SP.J.1263.2012.02132
Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol. 2012 Sep;9(3):305-17. doi: 10.3724/SP.J.1263.2012.02132. PMID: 23097661; PMCID: PMC3470030.
Copy Download .nbib Format: NLM
Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

The open cardiovascular medicine journal

Kelishadi R.
PMID: 21804638
Open Cardiovasc Med J. 2010;4:24-9. doi: 10.2174/1874192401004020024. Epub 2010 Feb 23.

Atherogenesis starts from the fetal life, and its natural course consists of interrelations between traditional risk factors and inflammatory, immune, and endothelial biomarkers. Even the early-stages of atherosclerotic lesions, i.e. fatty streaks present the features of chronic inflammation. Markers...

Cite
Kelishadi R. Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. Open Cardiovasc Med J. 2010;4:24-9doi: 10.2174/1874192401004020024.
Kelishadi, R. (2010). Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. The open cardiovascular medicine journal, 424-9. https://doi.org/10.2174/1874192401004020024
Kelishadi, Roya. "Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life." The open cardiovascular medicine journal vol. 4 (2010): 24-9. doi: https://doi.org/10.2174/1874192401004020024
Kelishadi R. Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. Open Cardiovasc Med J. 2010;4:24-9. doi: 10.2174/1874192401004020024. Epub 2010 Feb 23. PMID: 21804638; PMCID: PMC2840608.
Copy Download .nbib Format: NLM
Other considerations for treating bladder tuberculosis.

Urology annals

Saburi A, Safiabady M.
PMID: 24833830
Urol Ann. 2014 Apr;6(2):155-6.

No abstract available.

Cite
Saburi A, Safiabady M. Other considerations for treating bladder tuberculosis. Urol Ann. 2014;6(2):155-6
Saburi, A., & Safiabady, M. (2014). Other considerations for treating bladder tuberculosis. Urology annals, 6(2), 155-6.
Saburi, Amin, and Safiabady, Mahdi. "Other considerations for treating bladder tuberculosis." Urology annals vol. 6,2 (2014): 155-6.
Saburi A, Safiabady M. Other considerations for treating bladder tuberculosis. Urol Ann. 2014 Apr;6(2):155-6. PMID: 24833830; PMCID: PMC4021658.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16321 entries